109400 ⎘
Active agents used in cell culture processes, e.g. differentation Enzymes
Sub-classes:EXTRACELLULAR VESICLES DERIVED FROM HEMATOPOIETIC STEM CELLS OR HEMATOPOIETIC PROGENITOR CELLS AND USES THEREOF
#2STORAGE METHOD OF HUMAN CORNEAL ENDOTHELIAL CELLS AND/OR HUMAN CORNEAL ENDOTHELIAM PRECURSOR CELLS
#3DIAGNOSTIC METHOD OF A SKIN SHOWING SIGNS OF AGING
#4SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET-FAMILY PROTEINS
#5Methods of Epigenetic Analysis
#6INDUCIBLE REGULATORY T-CELL GENERATION FOR HEMATOPOIETIC TRANSPLANTS
#7SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET-FAMILY PROTEINS
#8GENERATION OF INDUCED PLURIPOTENT CELLS BY CRISPR ACTIVATION
#9AUGMENTATION OF CELL THERAPY EFFICACY INCLUDING TREATMENT WITH ALPHA, 1,3 FUCOSYLTRANSFERASE
#10SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET-FAMILY PROTEINS
#11SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET-FAMILY PROTEINS
#12AUGMENTATION OF CELL THERAPY EFFICACY INCLUDING TREATMENT WITH ALPHA 1,3 FUCOSYLTRANSFERASE
#13Selective oxidation of 5-methylcytosine by TET-family proteins
#14SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET-FAMILY PROTEINS
#15SKELETAL MUSCLE AUGMENTATION UTILIZING MUSCLE-DERIVED PROGENITOR COMPOSITIONS, AND TREATMENTS THEREOF
#16SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET-FAMILY PROTEINS
#17METHODS AND COMPOSITIONS FOR GENERATING HEMOGENIC ENDOTHELIAL CELLS FROM PLURIPOTENT STEM CELLS
#18METHODS AND COMPOSITIONS FOR PRODUCING RECOMBINANT COMPONENTS FOR USE IN FOOD AND OTHER PRODUCTS
#19DIFFERENTIATION OF HUMAN EMBRYONIC STEM CELLS
#20A STORAGE METHOD OF HUMAN CORNEAL ENDOTHELIAL CELLS AND/OR HUMAN CORNEAL ENDOTHELIAL PRECURSOR CELLS
#21ENGINEERED NEOCARTILAGE TISSUE COMPOSITIONS
#22DIFFERENTIATION OF HUMAN EMBRYONIC STEM CELLS
#23METHOD AND PLATFORM FOR DISRUPTING INTRACELLULAR MICROTUBULES
#24Methods for Printing Functional Human Neural Tissue
#25NF-B signaling pathway-manipulated dendritic cells
#26METHODS FOR MAKING INSULIN IN VIVO
#27Selective oxidation of 5-methylcytosine by TET-family proteins
#28PARTHENOGENIC ACTIVATION OF HUMAN OOCYTES FOR THE PRODUCTION OF HUMAN EMBRYONIC STEM CELLS
#29COMPOSITIONS AND METHODS FOR LONG TERM CULTURE OF HEPATOCYTES
#30Methods of Epigenetic Analysis
#31METHODS FOR THE SIMULTANEOUS EXPANSION OF MULTIPLE IMMUNE CELL TYPES, RELATED COMPOSITIONS AND USES OF SAME IN CANCER IMMUNOTHERAPY
#32METHODS AND SYSTEMS FOR IMPROVING CELLS FOR USE IN THERAPY
#33METHODS OF IDENTIFYING IMMUNOMODULATORY GENES
#34COMPOSITIONS AND METHODS FOR RAPID AND MODULAR GENERATION OF CHIMERIC ANTIGEN RECEPTOR T CELLS
#35DEVICES AND METHODS FOR PRODUCTION OF CELL AGGREGATES
#36Compositions and methods for differential Cas9 gene labeling and/or editing
#37ORGANOID COMPOSITIONS FOR THE PRODUCTION OF HEMATOPOIETIC STEM CELLS AND DERIVATIVES THEREOF
#38Methods of epigenetic analysis
#39METHODS OF EPIGENETIC ANALYSIS
#40Skeletal muscle augmentation utilizing muscle-derived progenitor compositions, and treatments thereof
#41REPROGRAMMING FIBROBLASTS TO RETINAL CELLS
#42Compositions and methods for modifying cell surface glycans
#43IMMUNE CELL ACTIVATION
#44ADDITION OF NUCLEASES DIRECTLY TO CELL CULTURE TO FACILITATE DIGESTION AND CLEARANCE OF HOST CELL NUCLEIC ACIDS
#45Generation of induced pluripotent cells by CRISPR activation
#46USE OF NOGGIN, AN ALK5 INHIBITOR AND A PROTEIN KINASE C ACTIVATOR, TO PRODUCE ENDOCRINE CELLS
#47Stem cell culture medium and method
#48Mesenchymal stem cells with enhanced immunosuppressive capability
#49SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET-FAMILY PROTEINS
#50SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET-FAMILY PROTEINS
#51Differentiation of human embryonic stem cells
#52SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET-FAMILY PROTEINS
#53Addition of nucleases directly to cell culture to facilitate digestion and clearance of host cell nucleic acids
#54Pancreatic endocrine cells and methods thereof
#55Differentiation of human embryonic stem cells
#56Generation of Endocrine Progenitor Cells from Human Pluripotent Stem Cells Using Small Molecules
#57Compositions comprising glucosylated hydroxymethylated bases
#58Anti-cancer T cells and their preparation using coenzyme A
#59DEVICES AND METHODS FOR PRODUCTION OF CELL AGGREGATES
#60Methods for identifying hydroxylated bases
#61Surface of a vessel with polystyrene, nitrogen, oxygen and a static sessile contact angle for attachment and cultivation of cells
#62Selective oxidation of 5-methylcytosine by TET-family proteins
#63Method for culture of stem cell
#64METHODS FOR PRODUCING MAMMALIAN PLURIPOTENT STEM CELL-DERIVED ENDODERMAL CELLS
#65Stabilization of enzyme-immobilized hydrogels for extended hypoxic cell culture
#66METHOD OF PRODUCING PROGENITOR CELLS FROM DIFFERENTIATED CELLS
#67EX-VIVO INTESTINAL CULTURE MODEL, METHODS OF PRODUCING SAME AND USES THEREOF
#68CULTURE MEDIUM FOR EPITHELIAL STEM CELLS AND ORGANOIDS COMPRISING THE STEM CELLS
#69Methods for distinguishing 5-hydroxymethylcytosine from 5-methylcytosine
#70SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET-FAMILY PROTEINS
#71SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET-FAMILY PROTEINS
#72Selective oxidation of 5-methylcytosine by TET-family proteins
#73REPROGRAMMING CARDIOMYOCYTES WITH ONE TRANSCRIPTION FACTOR
#74Small molecule compound composition that efficiently induces differentiation of human pluripotent stem cells into myocardial cells
#75Inducible regulatory t-cell generation for hematopoietic transplants
#76Augmentation of cell therapy efficacy including treatment with alpha 1,3 fucosyltransferase
#77Method for Inducing Targeted Differentiation of Human Stem Cells Toward Hepatic Cells
#78METHOD FOR SEPARATING AND EXTRACTING HUC-MSC FROM WHARTON'S JELLY TISSUE OF UMBILICAL CORD
#79Methods of enhancing female fertility
#80Detection of 5-hydroxymethylcytosine by glycosylation
#81Labeling hydroxymethylated residues
#82PLURIPOTENT STEM CELL CULTURE ON MICRO-CARRIERS
#83Use of a TGF-βR-1 kinase to produce human pancreatic endocrine cells
#84NF-KB signaling pathway-manipulated dendritic cells
#85Fusion molecule based on TAA variant
#86Selective oxidation of 5-methylcytosine by TET-family proteins
#87In-vitro embryonic culture medium comprising an inhibitor of cathepsin L and the use of the same in embryo cryopreservation
#88COMPOSITIONS AND METHODS FOR MODIFYING CELL SURFACE GLYCANS
#89TREATMENT OF PLURIPOTENT CELLS
#90Selective oxidation of 5-methylcytosine by TET-family proteins
#91Postnatal adherent cells and preparation method therefor
#92HUMAN STEM CELL-DERIVED NEURAL PRECURSORS FOR TREATMENT OF AUTOIMMUNE DISEASES OF THE CENTRAL NERVOUS SYSTEM
#93METHODS AND COMPOSITIONS FOR STEM CELL SELF-RENEWAL
#94Cancer immunotherapy
#95Methods for making pancreatic endocrine cells
#96Pancreatic endocrine cells and methods thereof
#97METHOD FOR CULTURING NORMAL CELLS AND ODONTOMA CELLS CONTAINED IN ORAL TISSUE
#98Differentiation of Human Embryonic Stem Cells
#99Immune-compatible cells created by nuclease-mediated editing of genes encoding HLA
#100Cardiomyocyte production
#101Selective oxidation of 5-methylcytosine by TET-family proteins
#102ENHANCED REPROGRAMMING TO IPS CELLS
#103Selective oxidation of 5-methylcytosine by TET-family proteins
#104Use of noggin, an ALK5 inhibitor and a protein kinase c activator to produce endocrine cells
#105Detection of 5-hydroxymethylcytosine by glycosylation
#106SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET-FAMILY PROTEINS
#107Selective oxidation of 5-methylcytosine by TET-family proteins
#108Selective oxidation of 5-methylcytosine by TET-family proteins
#109Fusion molecule based on novel TAA variant
#110Pluripotent cell lines and methods of use thereof
#111Mesenchymal stem cells with enhanced immunosuppressive capability
#112Mammalian neural plate border stem cells capable of forming neural tube and neural crest cell lineages including central and peripheral neurons
#113Stem cell culture medium and method
#114Methods of using an activator of cereblon for neural cell expansion and the treatment of central nervous system disorders
#115Methods and compositions for generating an immune response by inducing CD40 and pattern recognition receptor adapters
#116Methods for producing mammalian pluripotent stem cell-derived endodermal cells
#117Skeletal muscle augmentation utilizing muscle-derived progenitor compositions, and treatments thereof
#118Reprogramming fibroblasts into cardiomyocytes
#119Fusion molecule based on novel TAA variant
#120Therapeutic method using cardiac tissue-derived pluripotent stem cells
#121Cancer immunotherapy
#122Generation of Endocrine Progenitor Cells from Human Pluripotent Stem Cells Using Small Molecules
#123METHOD FOR TREATING ALS VIA THE INCREASED PRODUCTION OF FACTOR H
#124Differentiation of human pluripotent stem cells
#125Parthenogenic activation of human oocytes for the production of neuronal cells
#126Agent for promoting corneal endothelial cell adhesion
#127Methods for compact aggregation of dermal cells
#128Method for treatment of GM1 gangliosidosis
#129Differentiation of human embryonic stem cells
#130Agent for promoting corneal endothelial cell adhesion
#131TGIF2-induced reprogramming of hepatic cells to pancreatic progenitor cells and medical uses thereof
#132Methods, kits, and compositions for stem cell self-renewal
#133Automated methods for isolating regenerative cells from adipose tissue
#134Differentiation of human embryonic stem cells
#135Methods for producing single pluripotent stem cells and differentiation thereof
#136Cell culture medium and process for protein expression, said medium and process comprising a PAM inhibitor
#137Cells exhibiting neuronal progenitor cell characteristics and methods of making them
#138Compositions and methods for modifying cell surface glycans
#139Differentiation of human embryonic stem cells
#140HIGH-SAFETY PROCESS FOR THE PREPARATION OF PURIFIED STEM CELL FRACTIONS
#141Differentiation of human embryonic stem cells
#142Cardiomyocyte production
#143Pluripotent stem cell culture on micro-carriers
#144Differentiation of human embryonic stem cells
#145Use of PI3K M-TOR and AKT inhibitors to induce FOXP3 expression and generate regulatory T cells
#146Process for the preparation of disinfected human cell suspensions
#147Soft tissue and bone augmentation and bulking utilizing muscle-derived progenitor cells, compositions and treatments thereof
#148Apparatus and methods for cell isolation
#149Compositions and methods for obtaining cells to treat heart tissue
#150Culture medium for epithelial stem cells and organoids comprising the stem cells
#151Methods and apparatuses for isolating and preparing stem cells
#152Treatment of pluripotent cells
#153NF-κB signaling pathway-manipulated dendritic cells
#154Cell culture medium and process for protein expression, said medium and process comprising a PAM inhibitor
#155Methods and compositions for stem cell self-renewal
#156Cardiomyocyte- and/or cardiac progenitor cell-proliferating agent and method for proliferating cardiomyocytes and/or cardiac progenitor cells
#157Expandable cell source of neuronal stem cell populations and methods for obtaining and using them
#158Expansion of stem/progenitor cells by inhibition of enzymatic reactions catalyzed by the Sir2 family of enzymes
#159Cardiomyocyte production
#160Composition for maintaining function of platelets
#161Process for the preparation of disinfected human cell suspensions
#162Scaffold-based organotypic culture for the long-term cultivation of human epidermal stem cells
#163CELLS EXHIBITING NEURONAL PROGENITOR CELL CHARACTERISTICS AND METHODS OF MAKING THEM
#164Combined use of ribonuclease and artemisinin
#165Composition and method for differentiation of human embryonic stem cells
#166METHOD FOR PRODUCTION OF ARTIFICIAL PLURIPOTENT STEM CELL
#167INDUCTION, PROPAGATION AND ISOLATION OF LIVER PROGENITOR CELLS
#168Methods and compositions for stem cell self-renewal
#169Use of collagen type VII for maintaining and re-inducing osteogenic abilities of mesenchymal stem cells
#170TREATMENT OF HEART DISEASE
#171NON-VIRAL DELIVERY OF TRANSCRIPTION FACTORS THAT REPROGRAM HUMAN SOMATIC CELLS INTO A STEM CELL-LIKE STATE
#172METHOD OF PRODUCING PROGENITOR CELLS FROM DIFFERENTIATED CELLS
#173Automated systems and methods for isolating regenerative cells from adipose tissue
#174METHOD FOR PROLIFERATING HAIR FOLLICLE STEM CELLS
#175REGULATION OF EPITHELIAL TISSUE BY HEDGEHOG-LIKE POLYPEPTIDES, AND FORMULATIONS AND USES RELATED THERETO
#176CARDIOMYOCYTES AND METHODS OF PRODUCING AND PURIFYING CARDIOMYOCYTES
#177Stem Cell Culture Methods
#178Generation of an autologous stem cell library from human oocytes parthenogenetically activated by high or low oxygen tension
#179In Vitro Production Of Oligodendrocytes From Human Umbilical Cord Stem Cells
#180Differentiation of human pluripotent stem cells into cells expressing mature hepatocyte markers by 2D and bioreactor culture
#181Methods for modifying cell surface glycans
#182Compositions and methods for modifying cell surface glycans
#183[METHODS AND APPARATUSES FOR ISOLATING AND PREPARING STEM CELLS]
#184Cells, nucleic acid constructs, cells comprising said constructs and methods utilizing said cells in the treatment of diseases
#185Stem cell aggregate suspension compositions and methods of differentiation thereof
#186INFLUENZA HEMAGGLUTININ AND NEURAMINIDASE VARIANTS
#187Culture medium for epithelial stem cells and organoids comprising the stem cells
#188METHODS AND COMPOSITIONS TO ENHANCE VACCINE EFFICACY BY REPROGRAMMING REGULATORY T CELLS
#189Methods for expansion of hematopoietic stem and progenitor cells
#190Composition for reprogramming somatic cells to generate induced pluripotent stem cells, comprising Bmi1 and low molecular weight substance, and method for generating induced pluripotent stem cells using the same
#191Pharmaceutical composition containing human mesenchymal stem cell
#192Inducible regulatory T-cell generation for hematopoietic transplants
#193Expansion of Embryonic Stem Cells
#194Cleavage of Nanog by Caspases Mediates the Differentiation of Embryonic Stem Cells
#195Blockade of gamma-secretase activity to promote myelination by oligodendrocytes
#196Use of a rock inhibitor to sustain primary human keratinocytes in a proliferative state
#197Soft tissue and bone augmentation and bulking utilizing muscle-derived progenitor cells, compositions and treatments thereof
#198Selective oxidation of 5-methylcytosine by TET-family proteins
#199Cells exhibiting neuronal progenitor cell characteristics and methods of making them
#200DECELLULARIZATION METHOD FOR SCAFFOLDLESS TISSUE ENGINEERED ARTICULAR CARTILAGE OR NATIVE CARTILAGE TISSUE
#201METHODS FOR PREVENTING AGGREGATION OF ADIPOSE STROMAL CELLS
#202Compositions and methods for inhibiting MMSET
#203PLURIPOTENCY ASSOCIATED EPIGENETIC FACTOR
#204Human stem cell-derived neural precursors for treatment of autoimmune diseases of the central nervous system
#205Differentiation of human embryonic stem cells
#206Methods for Using Protein Kinase C-Theta Inhibitors in Adoptive Immunotherapy
#207Enzymatical modification of cell glycosylation using serum albumin and divalent cations
#208Compositions and methods for obtaining cells to treat heart tissue
#209Method of producing adipocytes from fibroblast cells
#210Pluripotent Stem Cells
#211Episomal reprogramming with chemicals
#212Cardiomyocyte production
#213Method for culture of stem cell
#214AUGMENTATION OF CELL THERAPY EFFICACY INCLUDING TREATMENT WITH ALPHA 1-3 FUCOSYLTRANSFERASE
#215DEVICES AND METHODS FOR PRODUCTION OF CELL AGGREGATES
#216Capsule of thermogenic cells for treating a metabolic disease
#217SHIP-DEFICIENCY TO INCREASE MEGAKARYOCYTE AND PLATELET PRODUCTION
#218NOGO-A Neutralizing Immunoglobulins for the Treatment of Neurological Diseases
#219Methods, kits, and compositions for stem cell self-renewal
#220METHODS OF FABRICATING ENHANCED TISSUE-ENGINEERED CARTILAGE
#221Influenza hemagglutinin and neuraminidase variants
#222Method for generating primate cardiovascular progenitor cells for clinical use from primate embryonic stem cells or embryonic-like state cells, and their applications
#223Improved Reprogramming of Mammalian Cells, and Cells Obtained
#224STEM-LIKE CELLS, METHOD FOR DE-DIFFERENTIATING MAMMALIAN SOMATIC CELLS INTO STEM-LIKE CELLS, AND METHOD FOR DIFFERENTIATING STEM-LIKE CELLS
#225Stem cells modified to facilitate threonine catabolism
#226Cosmetic use of a protein belonging to the ribonuclease family
#227Method of improving cell proliferation of pancreatic progenitor cells in a pancreatic cell culture
#228COMPOSITION COMPRISING CALCIUM IONS AND AT LEAST ONE PROTEOLYTIC ENZYME FOR USE IN THE IN VITRO AND IN VIVO REGENERATION OF CUTANEOUS AND CONNECTIVE TISSUES
#229Methods for compact aggregation of dermal cells
#230CELL POPULATION WITH ENHANCED TRANSPLANTATION ACTIVITY
#231mTOR inhibtors and mTOR signaling pathway inhibitors induce differentiation of human embryonic stem cells into the osteoblastic lineage
#232Apparatus and methods for cell isolation
#233Methods for producing dendritic cells with an siRNA that interferes with MAPKAPK2 expression
#234Combinations of proteins to enhance viability of stem cells and their progenitors before transplantation
#235CARDIOMYOCYTE-LIKE CELL CLUSTERS DERIVED FROM HBS CELLS
#236CELL COMPOSITIONS DERIVED FROM DEDIFFERENTIATED REPROGRAMMED CELLS
#237METHOD AND ASSAY FOR GLYCOSYLATION PATTERN DETECTION RELATED TO CELL STATE OF STEM CELLS
#238Method for isolating and culturing adult stem cells derived from human amniotic epithelium
#239Differentiation of Human Embryonic Stem Cells
#240Parthenogenic Activation of Human Oocytes for the Production of Human Embryonic Stem Cells
#241PROMOTING ECM PRODUCTION BY FIBROBLAST CELLS AND/OR PROMOTING MIGRATION OF FIBROBLAST CELLS IN A BIOLOGICAL SYSTEM
#242CONTRACEPTIVE METHODS AND COMPOSITIONS RELATED TO PROTEASOMAL INTERFERENCE
#243Parthenogenic Activation of Human Oocytes for the Production of Human Embryonic Stem Cells
#244Methods and compositions for the differentiation of stem cells
#245Agent for promoting corneal endothelial cell adhesion
#246METHODS AND COMPOSITIONS FOR GENERATING AN IMMUNE RESPONSE BY INDUCING CD40 AND PATTERN RECOGNITION RECEPTOR ADAPTERS
#247STABILISATION OF THE PHENOTYPIC PROPERTIES OF ISOLATED PRIMARY CELLS
#248Methods and compositions for stem cell self-renewal
#249Manipulation of ovarian primordial follicles
#250METHOD FOR ISOLATION OF CELL, SERUM-FREE CULTURE MEDIUM FOR CELL, AND METHOD FOR CULTURE OF CELL
#251Fusion molecule based on novel TAA variant
#252DENTINOGENESIS PROMOTER AND DENTINOGENIC PULP-CAPPING MATERIAL
#253Pluripotent cell lines and methods of use thereof
#254Early mesoderm cells, a stable population of mesendoderm cells that has utility for generation of endoderm and mesoderm lineages and multipotent migratory cells (MMC)
#255Protease resistant recombinant bacterial collagenases
#256Pluripotent Stem Cell Culture on Micro-Carriers
#257Trans-Differentiation And Re-Differentiation Of Somatic Cells And Production Of Cells For Cell Therapies
#258METHODS AND COMPOSITIONS RELATED TO MODULATING THE EXTRACELLULAR STEM CELL ENVIRONMENT
#259Differentiation of human pluripotent stem cells
#260Differentiation of human embryonic stem cells
#261Stem cell aggregate suspension compositions and methods of differentiation thereof
#262Methods, kits, and compositions for stem cell self-renewal
#263Methods, Surface Modified Plates and Compositions for Cell Attachment, Cultivation and Detachment
#264Cell growth
#265DEVICES AND METHODS FOR PRODUCTION OF CELL AGGREGATES
#266Induction, propagation and isolation of liver progenitor cells
#267Method for preparation of hepatocyte using ES cell
#268METHOD FOR MODIFYING CELLS
#269Use of PI3K M-TOR and Akt Inhibitors to Induce FOXP3 Expression and Generate Regulatory T Cells
#270Differentiation of human embryonic stem cells
#271Stem Cell Culture Medium and Method
#272Single pluripotent stem cell culture
#273Treatment of pluripotent cells
#274Cells exhibiting neuronal progenitor cell characteristics and methods of making them
#275GROWTH FACTORS FOR PRODUCTION OF DEFINITIVE ENDODERM
#276Pancreatic and Liver Endoderm Cells and Tissue by Differentiation of Definitive Endoderm Cells Obtained from Human Embryonic Stems
#277Phosphatases involved in the regulation of cardiomyocyte differentiation
#278COMPOSITIONS AND POPULATIONS OF CELLS OBTAINED FROM THE UMBILICAL CORD AND METHODS OF PRODUCING THE SAME
#279Method for purifying cardiomyocytes or programmed cardiomyocytes derived from stem cells or fetuses
#280Cells expressing pluripotency markers and expressing markers characteristic of the definitive endoderm
#281Antibody SACK-1 that binds CD44 glycoforms
#282Isolation and therapeutic application of adult retinal stem cells collected from extra-retinal tissues
#283METHODS AND MATERIALS RELATING TO ENHANCED PRODUCTION OF DOPAMINE NEURONS
#284Modulation of stem and progenitor cell differentiation, assays, and uses thereof
#285Methods, surface modified plates and compositions for cell attachment, cultivation and detachment
#286Immortalized hepatocyte cell line secreting modified insulin with glucose sensitivity
#287Method for propagating influenza virus
#288Influenza hemagglutinin and neuraminidase variants
#289Differentiation of human embryonic stem cells
#290COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING BRAIN CANCER AND IDENTIFYING NEURAL STEM CELLS
#291Cardiomyocytes and methods of producing and purifying cardiomyocytes
#292Multipotent stem cells from peripheral tissues and uses thereof
#293METHOD TO EXPAND nTREG CELLS USING PI-3K ANTAGONIST
#294METHOD TO EXPAND nTREG CELLS USING p70 S6 KINASE ANTAGONIST
#295Influenza hemagglutinin and neuraminidase variants
#296DIFFERENTIATION OF STEM CELLS AND STABILIZATION OF PHENOTYPICAL PROPERTIES OF PRIMARY CELLS
#297Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto
#298MEDIUM FOR CULTURING HEMATOPOIETIC CELLS AND A METHOD OF CULTURING HEMATOPOIETIC CELLS
#299Maintenance of Embryonic Stem Cells by the GSK-3 Inhibitor 6-Bromoindirubin-3'-Oxime
#300ANGIOGENIC CELLS FROM HUMAN PLACENTAL PERFUSATE